Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA
F:E28
|
RO |
|
C
|
China Pacific Insurance Group Co Ltd
XBER:75C
|
CN |
|
C
|
China Shenhua Energy Co Ltd
XMUN:IKF
|
CN |
|
Siemens AG
F:SIE
|
DE |
|
C
|
Cadence Design Systems Inc
XMUN:CDS
|
US |
|
Redefine Properties Ltd
F:R7H1
|
ZA |
|
A
|
Atmos Energy Corp
F:AEO
|
US |
Wall St Price Targets
RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for RYTM is 142.26 USD with a low forecast of 106.05 USD and a high forecast of 166.95 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RYTM's stock price target?
Price Target
142.26
USD
According to Wall Street analysts, the average 1-year price target for RYTM is 142.26 USD with a low forecast of 106.05 USD and a high forecast of 166.95 USD.
What is the Revenue forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
41%
The compound annual growth rate for Revenue over the next 8 years is 41%.
What is the Gross Profit forecast for Rhythm Pharmaceuticals Inc?
Projected CAGR
51%
The compound annual growth rate for Gross Profit over the next 6 years is 51%.
